SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits Fresh 52-Week High
- August 13, 2026
- Posted by: Harsh Piplani
- Category: News
SAI LIFE SCIENCES LIMITED traded at Rs 1467.65, up 0.29% today, after touching a fresh 52-week high of Rs 1475.70. Its market capitalisation stands at Rs 30,654.90 crore.
SAI LIFE SCIENCES LIMITED Share Price was at Rs 1467.65 on 13 August 2026 at 10:17 AM IST, up Rs 4.20 or 0.29% from the previous close of Rs 1463.45, after the stock touched a fresh 52-week high of Rs 1475.70. The company’s market capitalisation stood at Rs 30,654.90 crore, placing this one-year high move firmly on the radar of investors tracking Healthcare names.
Today’s move matters because the verified data confirms both a new yearly high and a positive intraday gain, even though the move itself is modest in percentage terms. The stock opened at Rs 1455.85, fell as low as Rs 1434.00, and then recovered to test higher levels during the session. Turnover stood at Rs 1.52 crore with volume of 10,324 shares, showing that the fresh 52-week peak came with active market participation.
For readers searching for SAI LIFE SCIENCES LIMITED Share Price Today, SAI LIFE SCIENCES LIMITED Stock News, or why the stock is rising today, the supplied data confirms the price event but does not establish a company-specific catalyst. What investors can assess immediately, however, is valuation, profitability and sector context. Univest finds that the stock is trading at a P/E of 68.39 and P/B of 10.82, while ROE stands at 18.65% and ROCE at 22.17%. Those figures make the stock worth tracking not just for price action, but also for how its premium valuation compares with Healthcare benchmarks and listed peers.
SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,467.65 |
| Previous Close | Rs 1,463.45 |
| Today's Change | +Rs 4.2 (+0.29%) |
| Day Open | Rs 1,455.85 |
| Fresh 52-Week High | Rs 1,475.7 |
| Day Low | Rs 1,434 |
| Current Volume | 10,324 |
| Turnover | Rs 1.52 crore |
| Market Capitalisation | Rs 30,654.9 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,467.65. versus the previous close of Rs 1,463.45, a rise of 0.29%. The stock opened at Rs 1,455.85, reached Rs 1,475.7, touched Rs 1,434. Reported volume was 10,324.
SAI LIFE SCIENCES LIMITED Share Price Today reflects a narrowly positive but notable session, with the stock rising 0.29% and setting a fresh 52-week high at Rs 1475.70. The session range, opening level, day low and turnover show that the stock tested both intraday weakness and fresh buying interest before holding near its upper range.
The stock was last seen at Rs 1467.65 versus a previous close of Rs 1463.45, which means the absolute gain was Rs 4.20. That is a small percentage move on the day, but the significance comes from the fact that the session high of Rs 1475.70 established a new 52-week high and a new one-year high for the stock. In practical terms, SAI LIFE SCIENCES LIMITED Share Price has entered a zone where market participants often monitor whether momentum can sustain above prior yearly highs.
The intraday pattern was active. The stock opened at Rs 1455.85, dipped to Rs 1434.00 and later climbed to Rs 1475.70, leaving a day range of Rs 41.70. That range is much wider than the closing gain alone suggests, indicating meaningful price discovery during the session. With turnover of Rs 1.52 crore and traded volume of 10,324 shares, the move was backed by actual activity rather than a static quote change.
For investors following SAI LIFE SCIENCES LIMITED Share Price, this is the core fact pattern from today’s trading: the stock is marginally higher on the day, but it has still printed a fresh 52-week peak. In Stock Market Today and Share Market Today screens, such names often attract attention because new highs can bring them into Market News, Stocks in News and 52 Week High Stocks discussions. The next step is to see whether the company’s financial profile supports the attention that this price action is drawing.
SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 30,654.9 crore |
| P/E Ratio | 68.39x |
| P/B Ratio | 10.82x |
| ROE | 18.65% |
| ROCE | 22.17% |
SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 68.39x, a P/B ratio of 10.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 18.65% and ROCE of 22.17%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 68.39x |
| Benchmark Median P/E | 21.07x |
| Benchmark Average P/E | 58.79x |
| Benchmark P/E Range | 0x to 3,374.81x |
| Company P/B Ratio | 10.82x |
| Benchmark Median P/B | 1.92x |
| Company ROE | 18.65% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | 22.17% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 30,654.9 crore |
| Benchmark Median Market Cap | Rs 140.78 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 68.39x, which is above the benchmark median of 21.07x, a difference of +224.58%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of 18.65%, which is above the benchmark median of 10.92%, a difference of +70.79%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of 22.17%, which is above the benchmark median of 13.29%, a difference of +66.82%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Beta Drugs Ltd. | BETA | 2,958.04 | 68.39 | 10.82 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,596.51 | 34.07 | 7.02 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,559.74 | 171.25 | 3.13 | 13.9 | 12.97 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,474.06 | 44.25 | 1.76 | -0.78 | 8.31 |
| NGL Fine-Chem Ltd. | NGLFINE | 2,137.26 | 43.8 | 6.4 | 27.9 | 33.91 |
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 68.39x compared with the displayed peer median of 44.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.65% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 22.17% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 30,654.9 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching SAI LIFE SCIENCES LIMITED
This stock is attracting attention because the fresh 52-week high combines event-driven momentum with a financial profile that stands out within the Healthcare sector. The verified data supports several reasons why SAI LIFE SCIENCES LIMITED Share Price is being closely tracked today.
- The stock touched a fresh 52-week high of Rs 1475.70 and was trading at Rs 1467.65, up 0.29% from the previous close.
- The intraday range from Rs 1434.00 to Rs 1475.70 shows active price action rather than a flat session.
- Turnover of Rs 1.52 crore and volume of 10,324 shares confirm live participation in the move.
- Market capitalisation of Rs 30,654.90 crore makes it one of the larger names in the supplied Healthcare comparison set.
- P/E of 68.39 and P/B of 10.82 show that the stock trades at a premium to sector medians and averages.
- ROE of 18.65% and ROCE of 22.17% are above sector benchmark medians and averages, adding fundamental context.
- Peer data shows strong scale and solid profitability, even though some peers offer lower valuations or higher return ratios.
About SAI LIFE SCIENCES LIMITED
SAI LIFE SCIENCES LIMITED, traded under the symbol SAILIFE, is part of the Healthcare sector. The supplied market data places it within a sector universe of 196 companies used for benchmark comparison. In current market tracking, the stock is being discussed primarily through its price action, valuation and profitability profile rather than any disclosed event-specific trigger in the supplied dataset.
Within the available Univest dataset, SAI LIFE SCIENCES LIMITED is best understood through its market position in Healthcare. Its market capitalisation of Rs 30,654.90 crore stands out sharply against both benchmark medians and the listed peers supplied alongside it. The company is being compared in the same research frame as businesses such as Beta Drugs, Dr Agarwals Eye Hospital, Sai Parenteral’s, Ind-Swift Laboratories and NGL Fine-Chem, which helps place its Share Price movement in a broader listed-sector context.
For readers following SAI LIFE SCIENCES LIMITED Latest News and company updates, today’s fresh 52-week peak has made the stock relevant not only as a Price Action story, but also as a valuation and sector comparison case within Healthcare.
Track SAI LIFE SCIENCES LIMITED Share Price on Univest
Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors using Univest can track SAI LIFE SCIENCES LIMITED Share Price through live market updates, 52-week levels, valuation ratios, sector comparisons and peer positioning. When a stock reaches a fresh one-year high, having these figures together helps separate simple momentum from broader financial context.
On Univest, users can monitor SAI LIFE SCIENCES LIMITED Share Price Today, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE and comparative sector benchmarks in one place. That makes it easier to follow SAI LIFE SCIENCES LIMITED Stock News, Share Price Update trends and broader Market Movers activity without relying only on headline price changes.
As this stock remains in focus after touching a fresh 52-week peak, the main things to monitor next are whether SAI LIFE SCIENCES LIMITED Share Price holds near current levels, how its premium valuation evolves against Healthcare peers, and whether profitability continues to justify that market positioning. Univest will remain a useful reference point for investors who want verified data-led tracking rather than speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest SAI LIFE SCIENCES LIMITED Share Price today?
Ans. SAI LIFE SCIENCES LIMITED Share Price was Rs 1467.65 on 13 August 2026 at 10:17 AM IST. The stock was up Rs 4.20, or 0.29%, from the previous close of Rs 1463.45 during the session.
Did SAI LIFE SCIENCES LIMITED hit a 52-week high today?
Ans. Yes, the stock touched a fresh 52-week high of Rs 1475.70 during the session. It later traded at Rs 1467.65, which kept SAI LIFE SCIENCES LIMITED Share Price close to its new one-year peak.
Why is SAI LIFE SCIENCES LIMITED Share Price rising today?
Ans. The supplied data confirms that the stock rose 0.29% and reached a fresh 52-week high today. However, the verified dataset does not establish a company-specific catalyst behind the move in SAI LIFE SCIENCES LIMITED Share Price.
What were the day’s open, high and low for SAI LIFE SCIENCES LIMITED?
Ans. The stock opened at Rs 1455.85, hit an intraday high of Rs 1475.70 and fell to a low of Rs 1434.00. That session range shows active intraday movement around the fresh 52-week high.
What is the market capitalisation of SAI LIFE SCIENCES LIMITED?
Ans. SAI LIFE SCIENCES LIMITED had a market capitalisation of Rs 30,654.90 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 140.78 crore and average of Rs 466.20 crore.
Is SAI LIFE SCIENCES LIMITED expensive compared with the Healthcare sector?
Ans. On the supplied numbers, the stock trades above broad Healthcare valuation benchmarks. Its P/E is 68.39 versus the sector median of 21.07, while its P/B is 10.82 against a sector median of 1.92.
How profitable is SAI LIFE SCIENCES LIMITED based on the supplied data?
Ans. The company shows ROE of 18.65% and ROCE of 22.17% in the supplied dataset. Both figures are above the Healthcare sector medians of 10.92% and 13.29%, respectively, indicating stronger return ratios.
How does SAI LIFE SCIENCES LIMITED compare with listed peers?
Ans. The stock has a much larger market capitalisation than peers such as Beta Drugs, Dr Agarwals Eye Hospital and NGL Fine-Chem. Its valuation is premium, while profitability is solid but not higher than every peer supplied.
What sector does SAI LIFE SCIENCES LIMITED belong to?
Ans. SAI LIFE SCIENCES LIMITED is classified in the Healthcare sector in the supplied dataset. The benchmark comparison in this article uses 196 same-sector companies to evaluate valuation, profitability and relative market positioning.
What should investors monitor after this fresh 52-week high?
Ans. Investors can watch whether the stock sustains near Rs 1475.70, how SAI LIFE SCIENCES LIMITED Share Price behaves after the breakout, and whether its premium valuation remains supported by ROE of 18.65% and ROCE of 22.17%.
